期刊文献+

去甲斑蝥素对Burkitt淋巴瘤Raji细胞株生物学特性的影响 被引量:1

Norcantharidin inhibits proliferation of Burkitt lymphoma Raji cells and induces cell cycle arrest
下载PDF
导出
摘要 目的:探讨去甲斑蝥素(nor-cantharidin,NCTD)对Raji细胞的增殖抑制及周期阻滞作用。方法:通过台盼蓝拒染法观察NCTD对Raji细胞及外周血单个核细胞(perip heralblood mononuclear cells,PBMC)的增殖抑制情况;甲基纤维素集落形成法观察NCTD对Raji细胞自我更新能力的影响;流式细胞仪检测Raji细胞周期变化。结果:NCTD抑制Raji细胞增殖,具有剂量时间依赖性(P<0.05),但是对单个核细胞增殖无影响(P>0.05);NCTD显著抑制Raji细胞的集落形成能力(P<0.05),NCTD使Raji细胞G2/M期细胞增多,G0/G1期细胞和S期细胞减少。结论:去甲斑蝥素能抑制Raji细胞增殖并产生G2/M期阻滞,且对Raji原始干祖细胞有抑制作用,有可能成为一种新的抗瘤制剂作用于人Burkitt淋巴瘤。 Objective To investigate the effects of Norcantharidin (NCTD) on human Burkitt lymphoma cell line Raji proliferation and cell cycle arrest in vitro. Methods Trypan blue assay was used to detect the inhibiting rate of NCTD on Raji cells and peripheral blood mononuclear cells (PBMC), in which concentration of NCTD were different. The self-renewal and.proliferating ability were examined by methylcellblose conlony-forming units (CFU) assay. The cell cycle were detected by flow cytometry. Results By using Trypan blue assay, we found that NCTD can inhibit the proliferation of Raji cells significantly in dose- and time-dependant manners (P 〈 0.05), whereas the effect on PBMC was not significant (P 〉 0.05). The CFU assay shows that the amount of colony-forming number decreased more in Raji cells administated with NCTD than in Raji cells which were pre-treated with NCTD for 48 h. The proportion of cells at the GJM stage increased while ones at the G0/Gl and S stage decreased. Conclusions NCTD inhibits the proliferation of Raji cells and induces cell cycle arrest at G2/M stage, and can strongly inhibit the growth of original Raji cells. NCTD may be useful for developing new therapeutic regimens for the treatment of human Burkitt lymphoma leukemia.
出处 《实用医学杂志》 CAS 北大核心 2012年第6期871-873,共3页 The Journal of Practical Medicine
基金 国家自然基金(编号:30973454)
关键词 去甲斑蝥素 RAJI细胞 细胞集落 细胞周期 Norcantharidin Raji cell Colony-forming Cell cycle
  • 相关文献

参考文献8

  • 1Deng L,Tang S.Norcantharidin analogues:a patent review (2006-2010)[J].Expert Opin Ther Pat,2011,21(11):1743-1753.
  • 2Youns M,Hoheisel J D,Efferth T.Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours[J].Curr Drug Discov Technol,2010,7(1):37-45.
  • 3Carbone A,Gloghini A,Aiello A,et al.B-cell lymphomas with features intermediate between distinct pathologic entities.From pathogenesis to pathology[J].Hum Pathol,2010,41(5):621-631.
  • 4Okebe J U,Skoetz N,Meremikwu M M,et al.Therapeutic interventions for Burkitt lymphoma in children[J].Cochrane Database Syst Rev,2011,6(7):D5198.
  • 5Chen Y C,Chang S C,Wu M H,et al.Norcantharidin reduced cyclins and cytokines production in human peripheral blood mononuclear cells[J].Life Sci,2009,84(7-8):218-226.
  • 6Sarma N J,Takeda A,Yaseen N R.Colony forming cell (CFC) assay for human hematopoietic cells[J].J Vis Exp,2010(46):2195.
  • 7Liao H F,Chen Y J,Chou C H,et al.Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production[J].Toxicol In Vitro,2011,25(1):206-212.
  • 8Yan Y, Cao P T, Greer P M, et al. Protein phosphatase 2A has an essential role in the activation of gamma-irradiation- induced G2/M checkpoint response [J]. Oncogene, 2010,29 (30) :4317-4329.

同被引文献26

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部